Financials

News Discussions Technicals Seasonals

PHAL fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

PharmaLundensis AB engages in the provision of biotechnology activities. It offers research and development of medicines and treatment for lung diseases such as chronic obstructive pulmonary disease, chronic bronchitis, and influenza. The company was founded by Staffan Skogvall in 2007 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

PHAL has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company